Johnson & Johnson has agreed to pay an estimated $5.5 billion to resolve tens of thousands of lawsuits alleging its talc-based products, including its iconic baby powder, caused ovarian cancer. The settlement aims to cover approximately 76,000 claims, representing nearly all outstanding talc-related cases in the U.S., and could bring an end to a legal battle that has spanned more than a decade.
The deal is contingent on acceptance by at least 95% of the claimants. While J&J maintains that the claims are without scientific merit and that its talc products are safe, the company stated the resolution allows it to put the matter behind it. The company expects to make an initial payment of up to $3 billion in 2027, with further payments to follow.